Serum miR-574-5p: A prognostic predictor of sepsis patients

Shock

Volumn 37, Issue 3, 2012, Pages 263-267

  Wang, Huijuan ^a,b   Meng, Kun ^c   Chen, Wei Jun ^d   Feng, Dan ^e   Jia, Yanhong ^a   Xie, Lixin ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

^b NANKAI UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

^d Chinese Academy of Sciences and China National Center for Bioinformation   (China)

^e CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

circulating miRNAs; Hsa miR 297; hsa miR 574 5p; microarrays; mortality

Indexed keywords

MICRORNA;

ADULT; AREA UNDER THE CURVE; ARTICLE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DEATH; FEMALE; GENE EXPRESSION; GENETIC ASSOCIATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; PROGNOSIS; QUANTITATIVE ANALYSIS; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEPSIS; SERUM; SURVIVAL; VALIDATION STUDY;

ADULT; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MICRORNAS; MIDDLE AGED; PROGNOSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEPSIS;

EID: 84863229880     PISSN: 10732322     EISSN: 15400514     Source Type: Journal    
DOI: 10.1097/SHK.0b013e318241baf8     Document Type: Article

References (29)

1. Lever A, Mackenzie I: Sepsis: definition, epidemiology, and diagnosis. BMJ 335:879-883, 2007. (Pubitemid 350069465)
2. Ferrer R, Artigas A, Suarez D, Palencia E, Levy MM, Arenzana A, Perez XL, Sirvent JM: Effectiveness of treatments for severe sepsis: a prospective, multicenter, observational study. Am J Respir Crit Care Med 180:861-866, 2009.
3. Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, et al.: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 358:125-139, 2008.
4. Padkin A, Goldfrad C, Brady AR, Young D, Black N, Rowan K: Epidemiology of severe sepsis occurring in the first 24 hrs in intensive care units in England, Wales, and Northern Ireland. Crit Care Med 31:2332-2338, 2003. (Pubitemid 37100836)
5. Lagos-Quintana M, Rauhut R, Lendeckel W, Tuschl T: Identification of novel genes coding for small expressed RNAs. Science 294:853-858, 2001. (Pubitemid 33032103)
6. Ambros V: The functions of animal microRNAs. Nature 431:350-355, 2004. (Pubitemid 39265675)
7. Krutzfeldt J, Poy MN, Stoffel M: Strategies to determine the biological function of microRNAs. Nat Genet 38(Suppl):S14YS19, 2006.
8. Bartel DP: MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 116:281-297, 2004.
9. Maier M, Wutzler S, Bauer M, Trendafilov P, Henrich D, Marzi I: Altered gene expression patterns in dendritic cells after severe trauma: implications for systemic inflammation and organ injury. Shock 30:344-351, 2008.
10. Chen X, Ba Y, Ma L, Cai X, Yin Y, Wang K, Guo J, Zhang Y, Chen J, Guo X, et al.: Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res 18:997-1006, 2008.
11. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O'Briant KC, Allen A, et al.: Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci USA 105:10513-10518, 2008.
12. Zhang Y, Liao Y, Wang D, He Y, Cao D, Zhang F, Dou K: Altered expression levels of miRNAs in serum as sensitive biomarkers for early diagnosis of traumatic injury. J Cell Biochem 112:2435-2442, 2011.
13. Lorenzen JM, Kielstein JT, Hafer C, Gupta SK, Kumpers P, Faulhaber-Walter R, Haller H, Fliser D, Thum T: Circulating miR-210 predicts survival in critically ill patients with acute kidney injury. Clin J Am Soc Nephrol 6:1540-1546, 2011.
14. Kong XY, Du YQ, Li L, Liu JQ, Wang GK, Zhu JQ, Man XH, Gong YF, Xiao LN, Zheng YZ, et al.: Plasma miR-216a as a potential marker of pancreatic injury in a rat model of acute pancreatitis. World J Gastroenterol 16:4599-4604, 2010.
15. Cermelli S, Ruggieri A, Marrero JA, Ioannou GN, Beretta L: Circulating microRNAs in patients with chronic hepatitis c and non-alcoholic fatty liver disease. PLoS One 6:e23937, 2011.
16. Farid WR, Pan Q, van der Meer AJ, de Ruiter PE, Ramakrishnaiah V, de Jonge J, Kwekkeboom J, Janssen HL, Metselaar HJ, Tilanus HW, et al.: Hepatocytederived micrornas as serum biomarker of hepatic injury and rejection after liver transplantation. Liver Transpl [epub ahead of print September 19, 2011] doi:10.1002/lt.22438.
17. Kuwabara Y, Ono K, Horie T, Nishi H, Nagao K, Kinoshita M, Watanabe S, Baba O, Kojima Y, Shizuta S, et al.: Increased microRNA-1 and microRNA-133a levels in serum of patients with cardiovascular disease indicate myocardial damage. Circ Cardiovasc Genet 4:446-454, 2011.
18. Vasilescu C, Rossi S, Shimizu M, Tudor S, Veronese A, Ferracin M, Nicoloso MS, Barbarotto E, Popa M, Stanciulea O, et al.: MicroRNA fingerprints identify miR-150 as a plasma prognostic marker in patients with sepsis. PLoS One 4:e7405, 2009.
19. Git A, Dvinge H, Salmon-Divon M, Osborne M, Kutter C, Hadfield J, Bertone P, Caldas C: Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. RNA 16:991-1006, 2010.
20. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, Schein RM, Sibbald WJ: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644-1655, 1992.
21. Gui J, Tian Y, Wen X, Zhang W, Zhang P, Gao J, RunW, Tian L, Jia X, Gao Y: Serum microRNA characterization identifies miR-885-5p as a potential marker for detecting liver pathologies. Clin Sci (Lond) 120:183-193, 2011.
22. Storey JD, Tibshirani R: Statistical significance for genomewide studies. Proc Natl Acad Sci USA 100:9440-9445, 2003. (Pubitemid 37033947)
23. Silvestre J, Povoa P, Coelho L, Almeida E, Moreira P, Fernandes A, Mealha R, Sabino H: Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med 35:909-913, 2009.
24. Meng FS, Su L, Tang YQ, Wen Q, Liu YS, Liu ZF: Serum procalcitonin at the time of admission to the ICU as a predictor of short-term mortality. Clin Biochem 42:1025-1031, 2009.
25. Castelli GP, Pognani C, Cita M, Paladini R: Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma. Crit Care Med 37:1845-1849, 2009.
26. Ranade AR, Cherba D, Sridhar S, Richardson P, Webb C, Paripati A, Bowles B, Weiss GJ: MicroRNA 92a-2*: a biomarker predictive for chemoresistance and prognostic for survival in patients with small cell lung cancer. J Thorac Oncol 5:1273-1278, 2010.
27. Foss KM, Sima C, Ugolini D, Neri M, Allen KE, Weiss GJ: miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer. J Thorac Oncol 6:482-488, 2011.
28. Borgan E, Navon R, Vollan HK, Schlichting E, Sauer T, Yakhini Z, Lingjaerde OC, Sorlie T, Borresen-Dale AL: Ischemia caused by time to freezing induces systematic microRNA and mRNA responses in cancer tissue. Mol Oncol 5:564-576, 2011.
29. Wang ZX, Bian HB, Wang JR, Cheng ZX, Wang KM, De W: Prognostic significance of serum miRNA-21 expression in human non-small cell lung cancer. J Surg Oncol 104:847-851, 2011.